Anette Henneberry

Title: Anette Henneberry: Innovator in Phospholipid Synthesis

Introduction

Anette Henneberry is a notable inventor based in California, recognized for his contributions to the field of biochemistry. His work primarily focuses on the cloning and expression of proteins involved in phospholipid synthesis. Henneberry's innovative research has significant implications for understanding lipid metabolism and related diseases.

Latest Patents

Henneberry holds a patent for the "Cloning of human choline ethanolaminephospho transferases synthesis of phosphatidyl choline phosphatidyle thanolamine and platelet activating factor." This patent reports the first cloning and expression of proteins capable of catalyzing choline- and ethanolaminephosphotransferase reactions (hCEPT1 and hCEPT2). Both coding regions predict highly hydrophobic proteins of 43-46.5 kDa with several predicted membrane spanning domains. A CDP-alcohol phosphotransferase motif has been identified in both hCEPT1 and hCEPT2. Site-directed mutagenesis was employed to differentiate the residues responsible for choline- versus ethanolamine-phosphotransferase activity. Notably, the mutation of glycine 156 of hCEPT1 abolished ethanolaminephosphotransferase activity, while cholinephosphotransferase activity remained intact.

Career Highlights

Anette Henneberry has made significant strides in his career, particularly through his research at Dalhousie University. His work has contributed to a deeper understanding of lipid synthesis and its biological importance. Henneberry's innovative approach to cloning and protein expression has positioned him as a key figure in his field.

Collaborations

Henneberry has collaborated with Christopher McMaster, enhancing the depth and breadth of his research. Their combined expertise has led to advancements in the understanding of phospholipid synthesis.

Conclusion

Anette Henneberry's contributions to the field of biochemistry, particularly in phospholipid synthesis, highlight his innovative spirit and dedication to scientific advancement. His patent and collaborative efforts continue to influence research in lipid metabolism.